Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies ; day:8 ; month:4 ; year:2021 ; pages:1-14
Cancer immunology immunotherapy ; (8.4.2021), 1-14
- Creator
-
Bareham, Bethany
Georgakopoulos, Nikitas
Matas-Céspedes, Alba
Curran, Michelle
Saeb-Parsy, Kourosh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-021-02897-5
- URN
-
urn:nbn:de:101:1-2021053012272901771515
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bareham, Bethany
- Georgakopoulos, Nikitas
- Matas-Céspedes, Alba
- Curran, Michelle
- Saeb-Parsy, Kourosh
- SpringerLink (Online service)
Other Objects (12)
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Immune biological rationales for the design of combined radio- and immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Immune biological rationales for the design of combined radio- and immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Immune biological rationales for the design of combined radio- and immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies